Pathology: mNSCLC - L2 - all population; non squamous - mNSCLC - L2 - all population; squamous - mNSCLC - L2 - all population;
mNSCLC - L2 - all population | non squamous - mNSCLC - L2 - all population | squamous - mNSCLC - L2 - all population | ||
CheckMate 078, 2019 | CheckMate 057, 2015 | CheckMate 017, 2015 | ||
nivolumab alone | 3 | T1 | T1 | T1 |
docetaxel | 0 | T0 | T0 | T0 |